Since 2013 the Global Cannabis Stock Index has represented the overall publicly-traded market for the medical and legal marijuana sector.
The Global Cannabis Stock Index, which is dollar-denominated and based upon the prices of the U.S. listing for each member, is rebalanced quarterly, with each member weighted equally at that time. For the 06/30/18 rebalancing, each stock was required to have an average daily trading value in excess of $400,000 and a minimum price of at least $.10 (10-day average) as of 06/15/18. Canadian or Australian companies must have a U.S. listing in order to be included. The dollar-volume threshold for Canadian or Australian companies includes both U.S. and Canadian or Australian volume.
The Global Cannabis Stock Index included 53 companies as of 06/30/18 (announced on 06/16/18 and based on data from 06/15/18), but MedReleaf was removed on July 26th following its acquisition, leaving 52.
Inclusion in the index is not an endorsement or recommendation of any company. The companies included are designed to represent the overall market for the medical and legal marijuana sector. To summarize, it includes both the good and the bad. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. Market Data © 2018 QuoteMedia. Data delayed 15 minutes unless otherwise indicated.
Visit and bookmark the data-driven, fact-based Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures to keep track of the cannabis stocks that generate industry sales of more than $2.5m per quarter.
Compare the index returns to Alan Brochstein's 420 Opportunity model portfolio on publicly-traded stock due diligence platform, 420Investor.com.
Discover the best strategies to capitalize on the Green Rush!